Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial

L. N. Yatham, S. Beaulieu, A. Schaffer, M. Kauer-Sant'Anna, F. Kapczinski, B. Lafer, V. Sharma, S. V. Parikh, A. Daigneault, H. Qian, D. J. Bond, P. H. Silverstone, N. Walji, R. Milev, P. Baruch, A. Da Cunha, J. Quevedo, R. Dias, M. Kunz, L. T. YoungR. W. Lam, H. Wong

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial'. Together they form a unique fingerprint.

Medicine & Life Sciences